Experience

Docmedia

• Dominican Republic
• Advertising Services
• 1 - 100 Employee

• General Manager at DocMedia Ltd

  • Aug 2020 - Present



Egis Pharmaceuticals PLC

• Hungary
• Pharmaceutical Manufacturing
• 700 & Above Employee

• International marketing manager

  • Apr 2010 - Present

  International Marketing Manager - Cardiology-Diabetology-UrologyMarketing: Developing central marketing materials with go to market strategies, digital channel CLM-CRM materials (from 2012), responsible for local adaptation of marketing materials, new product launch preparation for value added fix dose combinations (amlodipine+bisoprolol, ramipril+amlodipine, rosuvastatine+ezetimibe etc) with originator like strategy planning and implementation. Developing and launching a marketing Share point site (2014) for best practice sharing and common knowledge databaseManagement and Leadership: teaching and developing EGIS's affiliate marketing colleagues. Preparing and implementing standard operational processes (SOP) for HQ and affiliatesOrganizing International marketing meetings.Yearly business reviews in HQ (profit plan and marketing strategy reviews), local country visits for operative strategy implementation and fine tuning)Business development activities in cardiology and diabetology with cont. screening of target markets (high potential INNs for own development, lower potential INNs for license in)Market access (pricing and reimbursement): support market access procedures for value added and originator like products with go to market strategies



Merck

• United States
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Senior Customer and brand manager of Oncology portfolio

  • Nov 2009 - Mar 2010

  Senior product manager with responsibility of marketing strategy and communication for Emend (aprepitant), Temodal (temozolamide), Caelyx,(doxorubicin),Intron A (interferon alfa) among clinical oncologists, pulmonologists, gynecologists Senior product manager with responsibility of marketing strategy and communication for Emend (aprepitant), Temodal (temozolamide), Caelyx,(doxorubicin),Intron A (interferon alfa) among clinical oncologists, pulmonologists, gynecologists

• Senior Customer and brand manager of Oncology and Hospital business

  • Mar 2009 - Sep 2009

  Emend (aprepitant), Cancidas (capsofungin), MSD-HIV drugs Emend launch (aprepitant, 2009) – prepare a new Hungarian antiemetic guideline and adoptation among clinical oncologists , shaping their perception (KOLs and Advisory team of MoH)Isentress launch (raltegravir, 2009) positioning among antiHIV therapy

• Senior customer and brand manager of Rheumatology franchise

  • Dec 2007 - Mar 2009

  Arcoxia launch (etoricoxib, 2007) – rebuild the coxib's perception after rofecoxib withdrawal in HURelauch of Fosavance (alendronate+cholecalciferol, 2008) after getting back the reimbursement Fosavance 5600 launch (alendronate+cholecalciferol, 2009) with high dose of cholecalciferol among rheumatologist, endocrinologists, traumatologists, ortopedic surgeins.Build the endocronilogy perception of daily cholecalciferol demand for elderly patients.Working together with infliximab (anti TNF, biotechnology) team in rehumatology target promotion (rehumatoid arhtritis and Spondylitis Ankylopoetica (SpA))

• Senior Product Manager of Renitec (enalapril), Co-Renitec(enalapril HCT), Zocor (simvastatin)

  • May 2007 - Dec 2007

  Relaunch of Zocor, Co-Renitec (2007) – succesful antigeneric campaign with rented sales force (marketing and sales force management for 20 MRs)

• Senior Product Manager of Rotateq (pentavalent rotavirus vaccine) and MSD vaccines

  • Feb 2007 - Apr 2007

  preparing launch of rotavirus vaccine with medical/media campaign

• Product Manager of Fosamax (alendronate)/Fosavance (alendronate+cholecalciferol)

  • Jan 2004 - Jan 2007

  Make Fosamax OW 2nd best sellling drug in Hungary (4,6 B HUF)Relaunch of Fosamax (alendronate, 2005) with antigeneric campaign, protecting the market leader position and market shareFosavance launch (alendronate+cholecalciferol, 2006) - life cycle management - switching 60% of Fosamax patients within 3 months

• Product Manager of Vioxx (rofecoxib)

  • Jun 2003 - Dec 2003

• Senior Scientific associate

  • Apr 1999 - May 2003

  2000 Award of Excellence

• Scientific Associate

  • Oct 1996 - Mar 1999

  Sales promotion in 3 counties in Nothern Eastern Hungary (Borsod, Heves, Szolnok)Product champion of Tienam (imipenem), 1998 -higher sales in BAZ county than in capitalProduct champion of Fosamax (alendronate), 1999 - best sales and market share in Hungary